We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Medical Imaging Health IT Point of Care Business Focus

Glucagon Delivery System Treats Post-Bariatric Hypoglycemia

By HospiMedica International staff writers
Posted on 30 Jan 2020
Illustration
Illustration
A new study describes a closed-loop system that automatically provides patients with an appropriate, as-needed dose of liquid glucagon to treat post-bariatric hypoglycemia (PBH).

Developed by researchers at the Joslin Diabetes Center (Boston, MA, USA) and Harvard University (Cambridge, MA, USA), the system is comprised of a continuous glucose monitor (CGM) device and a patch infusion glucagon pump. A glucose-responsive automated delivery system detects hypoglycemia, which is then mitigated via an algorithmic application that delivers up to two doses of glucagon when triggered. The closed-loop system allows patients to go about their daily activities without the fear of dipping into dangerous hypoglycemia.

In a study of the system that involved 12 patients (mean age 52 years), hypoglycemia was induced in each patient after being hooked up to the system, and the algorithm was allowed to sense impending low blood sugar levels and automatically deliver an appropriate glucagon dose, under supervision by the medical team. The results showed that nadir plasma glucose was higher with glucagon that with placebo and that no rebound hyperglycemia occurred. The study was published on November 12, 2019, in The Journal of Clinical Endocrinology & Metabolism.

“Post-bariatric hypoglycemia is a profoundly life-altering condition for patients. Having unpredictable hypoglycemia that people can't detect is really an unsafe situation. This system provides a way to help individuals keep their glucose in a safe range,” said senior author Mary Elizabeth Patti, MD, of Harvard Medical School and Joslin. “Using the system to detect an upcoming severe low and treat it before it gets unsafe would be so important to improve safety and quality of life of patients with this type of hypoglycemia.”

“The way that we look at it, it is very similar to how in your car, you have an airbag. You don't use that airbag every time that you stop at a traffic light, but when there is a severe event and there's a need to prevent catastrophe, the airbag will be deployed,” said study co-author Eyal Dassau, PhD, director of the Biomedical Systems Engineering Research Group at Harvard. “We employing the same idea for the glucagon system: we detect, we analyze and then we deliver automatically a mini dose of glucagon. You can start with a very low dose of glucagon as it's needed, and add an additional small dose if indicated without overdosing.”

PBH can occur in the context of the dumping syndrome, which can occur postoperatively in up to half of gastric bypass patients with ingestion of simple sugars. Early dumping, a result of rapid emptying of food into the jejunum due to surgically altered anatomy, is characterized by flushing, tachycardia, abdominal pain, and diarrhea. Late dumping occurs after meal ingestion and is a consequence of the brisk insulin response to the hyperglycemia that results from the rapid absorption of simple sugars from the proximal small intestine.

Related Links:
Joslin Diabetes Center
Harvard University


Gold Member
12-Channel ECG
CM1200B
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Patient Monitoring System
AlarmSense
Radiofrequency Generator
GX1

Channels

Critical Care

view channel
Image Credit: Shutterstock

AI-Derived Heart Age Linked to Cardiovascular and Dementia-Related Mortality

Cardiovascular disease is increasingly associated with dementia-related mortality and other forms of age-related decline. Identifying people with greater long-term vulnerability before severe outcomes... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image Credit: Adobe Stock

Lung Ultrasound Predicts Progression of Interstitial Lung Abnormalities in Rheumatoid Arthritis

Interstitial lung abnormalities are a pulmonary concern in patients with rheumatoid arthritis, requiring monitoring to detect disease progression. However, tracking these changes often involves repeated... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more